Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical-controlled, multicenter, double-blind study

OBJECTIVE: To evaluate the efficacy and safety of conversion to lacosamide 400 mg/day monotherapy in adults with focal epilepsy. METHODS: This historical-controlled, double-blind study (NCT00520741) enrolled patients aged 16–70 years on stable doses of 1–2 antiepileptic drugs (AEDs) and experiencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Wechsler, Robert T, Li, George, French, Jacqueline, O'Brien, Terence J, D'Cruz, O'Neill, Williams, Paulette, Goodson, Robin, Brock, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2014
Materias:
Full-Length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477913/
https://www.ncbi.nlm.nih.gov/pubmed/24915838
http://dx.doi.org/10.1111/epi.12681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477913/
https://www.ncbi.nlm.nih.gov/pubmed/24915838
http://dx.doi.org/10.1111/epi.12681

Ejemplares similares